Print
Back to Results

EVOLVE-MI

Objective

The EVOLVE-MI trial is a pragmatic randomized multicenter trial of evolocumab administered very early to reduce the risk of cardiovascular events in patients hospitalized with acute myocardial infarction.

Research Study Categories

Specialties

  • Cardiology
Scroll to Top
X

Like most websites, we use cookies and other technologies to keep our website reliable, secure, and to better understand how our site is used. By using our site, you agree to our use of these tools. Learn More